Informed Consent Process Trips Up Many Clinical Registries – Consultant
This article was originally published in The Gray Sheet
Executive Summary
Underestimating the importance of the patient informed consent process is a common and costly mistake made by sponsors of medical device registries, according to Jeremy Tinkler, director of regulatory affairs at consulting firm MedPass International